Apyx Medical Corp. (NASDAQ: APYX) reported Q2 EPS of $0.09, $0.18 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $11.4 million versus the consensus estimate of $11.69 million.

For earnings history and earnings-related data on Apyx Medical Corp. (APYX) click here.